The recently determined structure of protein zero, P0, the most abundant peripheral nerve myelin protein, provides new insights into the molecular structure of myelin and potential disease mechanisms in hereditary peripheral neuropathies. The myelin sheath has evolved in vertebrates to achieve efficient propagation of electrical signals along nerve fibres. Myelin serves this purpose by providing electrical insulation of large caliber axons, a function that is reflected by its unique biochemical and structural features. The laminar myelin consists of the much extended plasma membranes of glia -Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS). During development, the glial membrane is continuously wrapped around the centrally-placed axon, closely apposing both the extracellular and the intracellular surfaces of the membrane to form compact myelin. Individual glial cells lay down distinct segments of myelin with the electrical characteristics of high resistance and low capacitance. The regions devoid of myelin between the segments are called nodes of Ranvier and contain the channel proteins that are responsible for the propagation of action potentials by saltatory conduction.
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The analysis of mutations affecting myelination has revealed a set of proteins that are essential for the development and maintenance of myelin structure and function [1] . Curiously, the myelin protein composition of mammals differs between the CNS and PNS, particularly with respect to the most abundant proteins. For example, proteolipid protein (PLP) is found exclusively in CNS myelin, whereas protein zero (P0) is restricted to the PNS. To what extent these proteins may serve similar functions in the two distinct tissues remains to be determined [2] .
When the primary amino acid sequence of P0 was revealed by cDNA cloning, it provided strong hints that this protein might be one of the key components in accomplishing and maintaining proper PNS myelin compaction [3] . A model was proposed suggesting that P0 may be responsible for maintaining the myelin 'intraperiod line' (see Fig. 1 ) by adhesive homotypic interactions between the extracellular, immunoglobulin-like domains of P0 proteins anchored in apposing membranes. It was further suggested that the 'major dense line' (see Fig. 1 ) might be held together by electrostatic interactions between the highly basic cytoplasmic domain of P0 and the negatively charged head groups of membrane phospholipids.
Numerous in vitro studies have subsequently provided evidence in support of these initial hypotheses and, with the advent of gene-targeting techniques in mice, conclusive evidence was obtained that P0 is indeed critically involved in the formation and maintenance of the myelin ultrastructure [4] . At the same time, genetic linkage analysis in human families revealed associations between mutations in the P0 gene and specific forms of hereditary motor and sensory neuropathies that are characterized by PNS myelin deficiencies, adding further support to view that P0 has a crucial role in the integrity of myelin [5] .
Initial attempts to determine how the structure of P0 is related to its function, and to correlate genotypes and phenotypes in patients with particular P0 mutations, were hampered by a lack of detailed structural information about P0. A major step in overcoming this limitation has now been taken by Shapiro et al. [6] , who have determined the three-dimensional structure of P0's unglycosylated extracellular domain, P0ex, at 1.9 Å resolution. What can we learn from their results? As predicted by computeraided analysis, the P0ex fold is similar to an immunoglobulin variable domain and clearly belongs to the same structure class. Most interestingly, P0ex oligomerizes within the crystal and the homotypic interactions observed may, if they occur in vivo, account at least in part, for the adhesion between opposing lamellae in myelin.This hypothesis is consistent with analytical ultracentrifugation analysis and the spacing between adjacent wraps of PNS myelin determined previously by X-ray diffraction analysis of intact myelin.
In addition to the protein-protein interactions between P0 molecules, analysis of the crystal structure suggests that the hydrophobic side chains of P0 residues Trp28 and, less likely, Trp78 may interact directly with the opposing membrane bilayer [6] . It is conceivable that the two types of interaction would be cooperative, reinforcing the formation of a network of adhesive forces that mediate myelin compaction at the intraperiod line. The combination of homophilic protein-protein interactions and direct tryptophan-membrane interactions may also provide the restraints that account for the regular intermembrane spacing observed in compact myelin.
With the P0ex structure at high resolution at hand, one might assume that a detailed structure-function analysis of this protein would now be straightforward, especially given the various P0 mutations that have been found to be associated with dominantly inherited motor and sensory neuropathies [7] . As this group of diseases is highly heterogeneous, as reflected in the clinical classification into the discrete subtypes Charcot-Marie-Tooth disease type 1B (CMT1B), Dejerine-Sottas syndrome (DSS) and congenital hypomyelination (CH), it might be possible to correlate specific genotypes with the corresponding phenotype.
Such a structure-function analysis is, indeed, now possible. For example, deletion of P0 residue Ser34 is expected, from the structural data, to lead to an unstable protein, so this mutation is likely to give a null allele, and patients carrying this mutation accordingly suffer from the relatively mild disease CMT1B. Replacement of Ser34 by a cysteine, however, leads to the severe DSS phenotype; this mutation generates an accessible free thiol group, which is likely to form disulfide aggregates that may act in a dominant-negative manner. In support of this interpretation, substitution of Arg69 by a cysteine residue also causes DSS, but the equivalent substitution of Tyr53, which is buried in the hydrophobic core of the protein, results in CMT1B and is probably a loss-of-function mutation. Furthermore, several other mutations associated with CMT1B have been suggested to interfere directly with P0-P0 interactions [6, 7] .
Inferences about disease mechanisms should, however, be treated with caution, in particular if the proteins affected are partners in large complexes. The misfolding of a mutant protein, or faulty interactions between a mutant protein and its partners, may lead to improper intracellular traffic, causing a general impairment of cellular physiology [8] . Such a mechanism may account for the effects of some PLP mutations in Pelizaeus-Merzbacher disease [9] . Alternatively, mutant P0 molecules, alone or in complexes, may be processed and transported correctly but exert dominant-negative effects by interfering with the complex network of wild-type P0 molecules.
Mutation may also interfere with the interactions between P0 and other proteins involved in the formation and maintenance of myelin, particularly as myelin is likely to require its components to be present in the correct stoichiometry for proper function [5] . The latter notion is supported by the finding that in one family with hereditary peripheral neuropathy, the parents affected by the mild CMT1B phenotype are heterozygotes for a frame-shift mutation at the codon for P0 residue Gly74 -which most likely generates a null allele -whereas the homozygous children are severely affected by DSS [7] . This view is also supported by the observed greater severity of the 
P0ex
----mutant phenotype in mice that are homozygous for a targeted mutation of the P0 gene, relative to mice heterozygous for the same mutation [4] .
Despite the recent progress in elucidating the structure and function of P0, a number of important questions remain open. For example, what role does P0's carbohydrate moiety play? The finding that the carbohydrate attachment site is mutated in one case of CMT1B [7] suggests it may be important. Does P0 engage in heterotypic interactions with other myelin proteins, and if so which ones? Is the expression of P0 in Schwann cells long before the start of myelination biologically relevant? The apparent delay in myelination in P0 mutant mice [4] suggests P0 plays a role in the initiation of myelination -but what role, precisely? How does the intracellular domain of P0 contribute to its clustering and adhesive properties, and interaction with the cytoskeleton [10] ? And, in this context, is it just by chance that the only known case of CH is due to a nonsense mutation in the intracellular domain of P0 [7] ? Following up on these and related questions should not only shed more light on the multiple roles of P0 in myelination, but may also help clarify disease mechanisms in hereditary neuropathies, with the ultimate goal of finding suitable therapies for the affected patients.
